Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Wenjia Zhu, Dan Xu, Li Huo and Han Wang
Objective: Age at onset has an impact on cardiac meta-iodobenzylguanidine (MIBG) uptake in Parkinson’s disease (PD), but not in other parkinsonism. In the present study, we hypothesized that there is an interaction between age at onset and disease group for heart-to-mediastinum (H/M) ratios.
Methods: Ninety-two patients with parkinsonism, including 60 patients with PD and 32 patients with other neurodegenerative parkinsonism, were retrospectively reviewed. Patients were grouped into the early-onset group (age at onset ≤50 y/o) and late-onset group (age at onset >50 y/o) according to the time they first developed motor symptoms. 131I-MIBG cardiac scintigraphy was done and heart-to-mediastinum ratio was used to quantify cardiac uptake.
Results: There was a statistically significant interaction between disease group and age at onset for both early (P=0.008) and delayed H/M ratio (P=0.043). Subgroup analysis demonstrated that no significant difference was found between PD and other neurodegenerative parkinsonism in the early-onset group for either early (2.03 ± 0.42 vs. 2.01 ± 0.29, P=0.882) or delayed H/M ratio (2.05 ± 0.56 vs. 2.22 ± 0.52, P=0.468). In patients with PD, there was significant difference in H/M ratio for both early (P=0.004) and delayed scan (P=0.002) between early-onset and lateonset patients. In patients with other neurodegenerative parkinsonism, no significant difference was found in H/M ratio for either early (P=0.314) or delayed scan (P=0.902) between early-onset and late-onset patients. Using ROC analysis, H/M ratio can be used to differentiate PD from other neurodegenerative parkinsonism (AUC=0.749 and 0.784 for early and delayed scan, respectively). By deselecting early-onset patients, the discrimination power can be further improved (AUC=0.812 and 0.824 for early and delayed scan, respectively) in late-onset patients.
Conclusion: There is an interaction between age at onset and disease group for H/M ratios. 131I-MIBG cardiac sympathetic imaging is less promising in differentiating PD from other parkinsonism for early-onset patients.